February 2011 Briefing - DermatologyLast Updated: March 01, 2011.
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for February 2011. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Educational Intervention for Skin Self-Examination Effective
FRIDAY, Feb. 25 (HealthDay News) -- Kidney transplant recipients (KTRs) are receptive to performing skin self-examinations (SSE) and acting on recommendations from an education intervention when they discover a concerning skin lesion, according to a study published online Feb. 21 in the Archives of Dermatology.
Androgenic Alopecia Tied to Prostate Cancer Risk
FRIDAY, Feb. 25 (HealthDay News) - Early-onset androgenic alopecia is associated with the development of prostate cancer later in life, according to a study published online Feb. 15 in the Annals of Oncology.
Melanoma May Affect Women's Quality of Life More Than Men's
THURSDAY, Feb. 24 (HealthDay News) -- Melanoma has a greater impact on health-related quality of life for women than for men, according to a study published in the February issue of the Archives of Dermatology.
Low Pay for New Female Doctors Tied to Gender, Not Job
MONDAY, Feb. 21 (HealthDay News) -- In 2008, male physicians who were newly trained in New York State made an average of $16,819 more than newly trained female physicians, compared to a $3,600 difference in 1999, according to a study published in the February issue of Health Affairs.
New U.S. Report on the Nation's Health 2010 Released
WEDNESDAY, Feb. 16 (HealthDay News) -- The U.S. Centers for Disease Control and Prevention's National Center for Health Statistics' 34th annual report, presenting the latest information on health status and determinants, utilization of health care, health care resources, expenditures, and a special feature on death and dying, was published Feb. 16.
Most Recalled Medical Devices Given Lenient Approval
TUESDAY, Feb. 15 (HealthDay News) -- The majority of medical devices recalled from 2005 to 2009 for risk of serious health hazard or death were approved by the less strict 510(k) process intended for devices considered low or moderate risk, according to a study published online Feb. 14 in the Archives of Internal Medicine.
Researchers Explore Nature of Difficult Clinical Encounters
MONDAY, Feb. 14 (HealthDay News) -- Both patients and physicians can bring qualities to a clinical encounter that result in its being perceived as difficult, and patients involved in these types of encounters have worse short-term outcomes, according to research published online Jan. 25 in the Journal of General Internal Medicine.
Cosmetic Surgery Procedures on the Rise in U.S.
THURSDAY, Feb. 10 (HealthDay News) -- Cosmetic plastic surgery procedures in the United States increased in 2010, according to the Report of the 2010 Plastic Surgery Statistics published online Feb. 7 by the American Society of Plastic Surgeons (ASPS).
Public Sector Plays Big Role in Drug Research
WEDNESDAY, Feb. 9 (HealthDay News) -- Public-sector research institutions (PSRIs) appear to play a bigger role in drug discovery than was previously thought, contributing to the discovery of about 10 to 20 percent of drugs approved for new drug applications since 1990, according to research published in the Feb. 10 issue of the New England Journal of Medicine.
Bacteria May Play a Role in Pustular and Ocular Rosacea
WEDNESDAY, Feb. 2 (HealthDay News) -- Staphylococcus epidermidis (S. epidermidis) may be involved in pustular and ocular rosacea, according to research published in the January issue of the Journal of the American Academy of Dermatology.
Adoptive Immunotherapy Used to Treat Epithelial Cancer
WEDNESDAY, Feb. 2 (HealthDay News) -- A T-cell receptor (TCR)-based gene therapy directed against NY-ESO-1 cancer/testis antigen may represent a new therapeutic approach for patients suffering from melanoma and synovial cell sarcoma, according to a study published online Jan. 31 in the Journal of Clinical Oncology.
|Previous: February 2011 Briefing - Cardiology||Next: February 2011 Briefing - Diabetes & Endocrinology|
Reader comments on this article are listed below. Review our comments policy.